Acadia Healthcare (NASDAQ:ACHC – Get Free Report) had its target price reduced by investment analysts at Barclays from $83.00 to $76.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price target indicates a potential upside of 21.78% from the stock’s previous close.
A number of other research firms have also recently issued reports on ACHC. Cantor Fitzgerald reiterated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Monday, August 19th. Deutsche Bank Aktiengesellschaft increased their target price on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $86.67.
Check Out Our Latest Stock Analysis on ACHC
Acadia Healthcare Price Performance
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $796.00 million during the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.92 EPS. On average, research analysts expect that Acadia Healthcare will post 3.51 EPS for the current year.
Hedge Funds Weigh In On Acadia Healthcare
Several hedge funds have recently modified their holdings of the stock. New York State Teachers Retirement System lifted its stake in Acadia Healthcare by 0.3% in the 1st quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock valued at $6,025,000 after purchasing an additional 200 shares during the last quarter. Blue Trust Inc. lifted its position in Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the last quarter. Commonwealth Equity Services LLC lifted its position in Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after acquiring an additional 257 shares during the last quarter. Quent Capital LLC lifted its position in Acadia Healthcare by 8.1% during the first quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock worth $300,000 after acquiring an additional 284 shares during the last quarter. Finally, Retirement Systems of Alabama lifted its position in Acadia Healthcare by 0.3% during the first quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock worth $9,174,000 after acquiring an additional 303 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Are Some of the Best Large-Cap Stocks to Buy?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.